Breast Cancer 1 (BRCA1) Peptid
BRCA1
Reaktivität: Human
Wirt: Synthetic
BP
-
- Target Alle BRCA1 Produkte
- BRCA1 (Breast Cancer 1 (BRCA1))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-BRCA1 Antibody reactivity.
-
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- BRCA1 (Breast Cancer 1 (BRCA1))
- Synonyme
- BRCAI Peptide, BRCC1 Peptide, BROVCA1 Peptide, IRIS Peptide, PNCA4 Peptide, PPP1R53 Peptide, PSCP Peptide, RNF53 Peptide, iris Peptide, pscp Peptide, brcai Peptide, brcc1 Peptide, rnf53 Peptide, brca1 Peptide, BRCA1 Peptide, LOC100224649 Peptide, BRCA1, DNA repair associated Peptide, breast cancer 1 Peptide, breast cancer 1, early onset Peptide, breast cancer 1 L homeolog Peptide, BRCA1 Peptide, brca1 Peptide, LOC755086 Peptide, Brca1 Peptide, brca1.L Peptide
- Hintergrund
- RNF53, Breast cancer type 1 susceptibility protein, RING finger protein 53
- Gen-ID
- 672
- UniProt
- P38398
-
Sie sind hier:
